Biofile has added a new test to its product portfolio: AspirinWorks. This is the only FDA-cleared test available on the markets helping doctors accurately determine aspirin effect by measuring the urine levels of a metabolite of thromboxane, the target of aspirin therapy.

In the United States, approximately one out of every four people are resistant to the beneficial effect of aspirin. Aspirin-resistance means that taking aspirin daily is having no effect whatsoever on your risk for heart attack or stroke.

For more information about AspirinWorks, please visit http://www.aspirinworks.com/